Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03341416
Other study ID # 102178/2015
Secondary ID
Status Recruiting
Phase N/A
First received October 30, 2017
Last updated November 13, 2017
Start date September 1, 2017
Est. completion date January 1, 2019

Study information

Verified date November 2017
Source University of Sao Paulo General Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Cerebellar ataxias are a group of disorders caused by cerebellar affections, for which currently no specific treatment is available. Some limited studies verified the effects of cerebellar transcranial magnetic stimulation (TMS) on ataxic symptoms, with good results. The hypothesis is that cerebellar TMS could improve ataxic symptoms in some patients and in these patients, chronic cerebellar stimulation through deep brain stimulation could be a therapeutic option. The rationale is to stimulate the dentate nucleus of the cerebellum in order to balance the functional asymmetry observed between both motor cortices after chronic cerebellar lesions.


Description:

Ten patients with cerebellar ataxia will be included in our protocol. Ataxia might be due to several aetiologies, from degenerative to genetic and vascular diseases. The initial focus is vascular and spinal cerebellar ataxias. The participants will be submitted to a neuronavigation protocol for the precise location of the dentate nucleus contralateral to the most symptomatic side. After that, the participants will be randomly assigned to 5 active or 5 placebo sessions of 1Hz TMS over the located area. After the first 5 sessions and a period of at least 4 weeks washout, the participants will cross over and receive other 5 sessions, active or sham. Clinical and video evaluations will be conducted before and after active and sham cluster of sessions. The good responders, i.e., with over than 30% of improvement after the active section will be eligible to bilateral dentate nucleus DBS. After that, again, a cross-over double blind on-off stimulation will be performed. Each period (on or 0ff-stimulation) will last 4 weeks.


Recruitment information / eligibility

Status Recruiting
Enrollment 10
Est. completion date January 1, 2019
Est. primary completion date July 1, 2018
Accepts healthy volunteers No
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria:

1. Patients with diagnosis of chronic cerebellar ataxia (> 6 months);

2. Age =18 years;

3. Be able to understand study protocol;

4. Signed, written informed consent (approved by the Institutional Ethics Committee) obtained prior to any study procedure;

5. Refractory symptoms response to first, second and third line pharmacological treatment;

6. Daily living activities impaired because the ataxia;

7. Be able to undergo surgery procedures.

Exclusion Criteria:

1. Abuse of alcohol, drugs

2. Known psychiatric conditions

3. Contraindications to DBS

4. Heart failure or cardiac disease that contraindicates surgery procedures;

5. Pacemaker or other stimulators implanted active;

6. Positive blood ß-HCG test for women;

7. Other medical conditions demand hospitalization; Participation in other clinical studies at the same time;

Study Design


Related Conditions & MeSH terms


Intervention

Device:
deep brain stimulation on stimulation - active
bilateral deep brain stimulation reaching the dentate nucleus turned ON - phase active
deep brain stimulation off stimulation - sham
bilateral deep brain stimulation reaching the dentate nucleus turned OFF - phase sham

Locations

Country Name City State
Brazil Rubens Cury São Paulo SP

Sponsors (1)

Lead Sponsor Collaborator
University of Sao Paulo General Hospital

Country where clinical trial is conducted

Brazil, 

Outcome

Type Measure Description Time frame Safety issue
Primary Primary outcome - change in Scale for the assessment and rating of ataxia - SARA To evaluate prospectively the effect of DN-DBS in ataxia. The primary outcome is the change between the Scale for the assessment and rating of ataxia (SARA, ranging from 0-40, higher scores mean more severe ataxia) at baseline and after surgery during the active DBS-ON phase change in the SARA score between the baseline versus after surgery during ON-stimulation deep brain stimulation phase. This phase lasts 1 month, so the evaluation will be performed 01 months after the stimulation is turned on.
Secondary Secondary outcome - change in tremor score using the Fahn Tolosa Marin Scale To evaluate prospectively the effect of DN-DBS on tremor. The secondary outcome is the change between the Fahn Tolosa Marin Scale (ranging from 0-40, higher scores mean worse tremor) at baseline and after surgery during the active DBS-ON phase change in the Fahn Tolosa Marin Scale score between the baseline versus after surgery during ON-stimulation deep brain stimulation phase. This phase lasts 1 month, so the evaluation will be performed 01 months after the stimulation is turned on.
Secondary Secondary outcome - quality of life To evaluate prospectively the effect of DN-DBS on quality of life. The secondary outcome is the change between the World Health Organization Quality of Life (WHOQOL-bref, 26 items, which measure the following broad domains: physical health, psychological health, social relationships, and environment, higher scores mean better quality of life) at baseline and after surgery during the active DBS-ON phase change in the WHOQOL-bref score between the baseline versus after surgery during ON-stimulation deep brain stimulation phase. This phase lasts 1 month, so the evaluation will be performed 01 months after the stimulation is turned on.
See also
  Status Clinical Trial Phase
Recruiting NCT04039048 - Effect of ctDCS During Balance Training on Cerebellar Ataxia N/A
Not yet recruiting NCT04054726 - A Study on Cerebello-Spinal tPCS in Ataxia N/A
Completed NCT02887703 - Augmenting Balance in Individuals With Cerebellar Ataxias N/A
Completed NCT02540655 - Efficacy and Safety Study of Stemchymal® in Polyglutamine Spinocerebellar Ataxia Phase 2
Recruiting NCT01958177 - Clinical Study to Evaluate the Safety and Efficacy BMMNC in Cerebellar Ataxia Phase 1/Phase 2
Recruiting NCT03972202 - The Role of Cerebellum in Speech N/A
Completed NCT05095870 - Evaluation of the Peripheral Nerve Ultrasound as a Diagnostic Tool in CANVAS Neuropathies
Completed NCT04790981 - Effect of Motor Imagery Training on Ataxic Children After Medulloblastoma Resection N/A
Completed NCT02900508 - Virtual Reality-based Training in Cerebellar Ataxia N/A
Active, not recruiting NCT05024240 - Interaction of the Cognitive and Sensory-cognitive Tasks With Postural Stability in Individuals With Stability Disorders N/A
Completed NCT00006492 - Gluten-Free Diet in Patients With Gluten Sensitivity and Cerebellar Ataxia N/A
Completed NCT01649687 - Treatment of Cerebellar Ataxia With Mesenchymal Stem Cells Phase 1/Phase 2
Completed NCT04750850 - Core Stability Exercises and Hereditary Ataxia N/A
Active, not recruiting NCT05157802 - Promoting Physical Activity Engagement for People With Early-stage Cerebellar Ataxia Phase 1
Completed NCT05278091 - Evaluation of the Diagnostic Value of Video-oculography in CANVAS Neuronopathies
Completed NCT05436262 - Using Real-time fMRI Neurofeedback and Motor Imagery to Enhance Motor Timing and Precision in Cerebellar Ataxia N/A
Active, not recruiting NCT06152133 - Telerehabilitation, Core Stability Exercises and Hereditary Ataxia (TRCore-ataxia) N/A
Completed NCT04648501 - Dual Task Training for Cerebellar Ataxia N/A
Enrolling by invitation NCT03269201 - Brain Network Activation in Patients With Movement Disorders
Completed NCT00202397 - Effect of Riluzole as a Symptomatic Approach in Patients With Chronic Cerebellar Ataxia Phase 2